Plus Therapeutics Reports Third Quarter 2022 Financial Results and Business HighlightsGlobeNewsWire • 10/20/22
Plus Therapeutics Presents Preliminary Safety and Feasibility Data from ReSPECT-LM Clinical Trial at the European Association of Nuclear Medicine CongressGlobeNewsWire • 10/19/22
Plus Therapeutics to Announce Third Quarter 2022 Financial Results and Host Conference Call on October 20, 2022GlobeNewsWire • 10/06/22
Plus Therapeutics Announces Patient Webinar in Recognition of Breast Cancer Awareness MonthGlobeNewsWire • 10/05/22
Plus Therapeutics to Share Data in Oral Presentations from Ongoing ReSPECT™ Clinical Trials at the 35th Annual Congress of the European Association of Nuclear MedicineGlobeNewsWire • 10/04/22
Plus Therapeutics Executes $17.6 Million Award Contract with Cancer Prevention & Research Institute of TexasGlobeNewsWire • 09/22/22
Plus Therapeutics Presents Positive Phase 1 Data from ReSPECT-GBM Clinical Trial at the European Society for Medical Oncology Congress 2022GlobeNewsWire • 09/12/22
Plus Therapeutics to Present In-Person at the H.C. Wainwright 24th Annual Global Investment ConferenceGlobeNewsWire • 09/08/22
Plus Therapeutics Announces Summary of FDA Meeting on Company's cGMP Manufacturing Process for Lead Drug CandidateGlobeNewsWire • 08/29/22
Plus Therapeutics to Present Data from ReSPECT-GBM™ Clinical Trial at the European Society for Medical Oncology Congress 2022GlobeNewsWire • 08/23/22
Plus Therapeutics Presents Positive Data from Ongoing ReSPECT™ Clinical Trials at the Annual Conference on CNS Clinical Trials and Brain MetastasesGlobeNewsWire • 08/13/22
Plus Therapeutics to Present Data from Ongoing ReSPECT™ Clinical Trials at the Annual Conference on CNS Clinical Trials and Brain MetastasesGlobeNewsWire • 07/28/22
Plus Therapeutics to Present at Inaugural Targeted Radiopharmaceuticals SummitGlobeNewsWire • 07/27/22
Plus Therapeutics, Inc. (PSTV) CEO Dr. Marc Hedrick on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 07/21/22
Plus Therapeutics Reports Second Quarter 2022 Financial Results and Business HighlightsGlobeNewsWire • 07/21/22
Plus Therapeutics to Announce Second Quarter 2022 Financial Results and Host Conference Call on July 21, 2022GlobeNewsWire • 07/13/22
Plus Therapeutics Successfully Completes Key Milestone for cGMP Manufacture of Lead Investigational RadiotherapeuticGlobeNewsWire • 07/12/22